Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.46%
1,101.23
-5.13
-0.46%
—1,106.361,105.681,109.291,096.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.42%
612.83
+2.57
+0.42%
—610.29610.29616.60610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.69%
1,219.52
+8.30
+0.69%
—1,211.221,211.011,221.411,208.50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.41%
1,757.89
+7.18
+0.41%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.58%
631.82
+3.65
+0.58%
—628.17629.38634.09629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.29%
857.08
+2.55
+0.29%
—854.57855.71860.09855.45——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.60%
215.57
-1.30
-0.60%
—216.87216.87217.79215.51——
SIXT
Technology
SIXT
Technology
SIXT
+1.41%
3,612.33
+50.39
+1.41%
—3,561.943,571.443,628.583,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.11%
904.34
+1.03
+0.11%
—903.31903.26906.56901.18——
SIXV
Health care
SIXV
Health care
SIXV
-0.18%
1,478.85
-2.69
-0.18%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.24%
2,405.72
+5.77
+0.24%
—2,399.952,404.452,418.812,398.09——
GLUE:NASDAQ
Monte Rosa Therapeutics Inc
$18.86
-0.55%
(-0.10) 1D
May 14, 2:28:57 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLUE...
Open
$18.98
High
$19.26
Low
$18.60
Mkt. cap
1.59B
Avg. vol.
868.78K
Volume
193.87K
52-wk high
$25.77
52-wk low
$3.51
EPS
-$1.46
Beta
1.62
Shares outstanding
84.48M
No. of employees
187
News stories
From sources across the web
About Monte Rosa Therapeutics Inc
CEO-
Employees187
Founded2019
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitemonterosatx.com
Last report
May 7, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.45 / -$0.38
-19.07%miss
Revenue / Est. (USD)
4.21M / 11.39M
-63.02%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
23.19M
12.77M
2.78M
4.21M
Cost of goods sold
29.04M
34.65M
39.89M
41.82M
Cost of revenue
29.04M
34.65M
39.89M
41.82M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.70M
11.09M
12.60M
12.42M
Operating expense
9.70M
11.09M
12.60M
12.42M
Total operating expenses
38.75M
45.74M
52.50M
54.24M
Operating income
-15.55M
-32.98M
-49.72M
-50.03M
Other non operating income
-
-
-
-
EBT including unusual items
-11.10M
-30.26M
-46.08M
-44.45M
EBT excluding unusual items
-11.10M
-30.26M
-46.08M
-44.45M
Income tax expense
1.20M
-3.18M
59.00K
52.00K
Effective tax rate
-10.81%
10.50%
-0.13%
-0.12%
Other operating expenses
-
-
-
-
Net income
-12.30M
-27.08M
-46.14M
-44.50M
Net profit margin
-53.01%
-212.10%
-1,658.94%
-1,057.08%
Earnings per share
-0.15
-0.33
-0.55
-0.45
Interest and investment income
3.07M
2.75M
3.69M
5.59M
Interest expense
-
-
-
-
Net interest expenses
3.07M
2.75M
3.69M
5.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.43M
-30.88M
-47.63M
-48.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer